Document is current
Any future updates will be listed below
-
Authors
Di Pietro, Francesca Romana
Marinelli, Daniele
Verkhovskaia, Sofia
Poti, Giulia
Falcone, Rosa
Carbone, Maria Luigia
Morelli, Maria Francesca
Zappalà, Albina Rita
Di Rocco, Zorika Christiana
Morese, Roberto
Piesco, Gabriele
Chesi, Paolo
Marchetti, Paolo
Failla, Cristina Maria
De Galitiis, Federica
-
Funding
Funding for this research was provided by:
Italian Ministry of Health, Ricerca Corrente (RC2022-2024, RC2022-2024, RC2022-2024)
- License Information
-
More Information
Article History
Received: 5 August 2024
Accepted: 18 September 2024
First Online: 1 October 2024
Declarations
:
: The study was conducted in accordance with the Declaration of Helsinki and approved by the Institutional Ethical Committee of IDI-IRCCS (protocol n. 510/3, 2018). As this is a retrospective analysis, authors made every effort to obtain written informed consent from each individual involved in the study.
: Not Applicable.
: The authors declare no competing interests.
: FdG has been a speaker at BMS, and Novartis conference. PM had a consultant/advisory role for BMS, ROCHE Genentech, MSD, Novartis, AMGEN, Merck Serono, Pierre Fabre, INCYTE. The two authors declare that this research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. All other authors declare no conflict of interest.
